• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型强直性肌营养不良中的器官功能障碍和肌肉残疾

Organ dysfunction and muscular disability in myotonic dystrophy type 1.

作者信息

Kaminsky Pierre, Poussel Mathias, Pruna Lelia, Deibener Joëlle, Chenuel Bruno, Brembilla-Perrot Béatrice

机构信息

From Médecine Interne (PK, LP, JD), Laboratoire d'Explorations Fonctionnelles Respiratoires (MP, BC), Cardiologie (BBP), Centre de Référence des Maladies Neuromusculaires (PK), and EA3450-Nancy-Université (MP, BC); Faculté de Médecine, and Centre Hospitalier Universitaire de Nancy, Hôpitaux de Brabois, Vandoeuvre, France.

出版信息

Medicine (Baltimore). 2011 Jul;90(4):262-268. doi: 10.1097/MD.0b013e318226046b.

DOI:10.1097/MD.0b013e318226046b
PMID:21694643
Abstract

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder characterized by muscle weakness and multiple organ impairment, especially the eyes, lung, and heart. We conducted the current study to analyze the prevalence and intercorrelation among these disorders and their respective relationships with muscular disability. We assessed medical history, anthropometric data, lung volumes, arterial and venous blood samples, surface 12-lead electrocardiogram, echocardiography, ophthalmologic examination, and muscular impairment rating scale (MIRS) in 106 patients (48 male and 58 female) with DM1, aged 43.7 ± 12.8 years. Obesity, hypertriglyceridemia, and diabetes were found in respectively 25.6%, 47.6%, and 17.1% of patients. Disabling cataract was found in 43.4%, and was independently predicted by age and MIRS. Restrictive lung disease was noted in 34%, and was predicted by MIRS, CTG repeat expansion, and body mass index. Conduction disorders were found in 30.2% of patients and were predicted by left ventricular ejection fraction, MIRS, and CTG repeat expansion.We found significant relationships between cataract, restrictive lung disease, and conduction disorders: patients with cataract and those with conduction disorders exhibited more severe restrictive lung disease than the other patients. Conversely, the relative risk of restrictive lung disease was 2.42 (1% confidence interval [CI], 1.06-5.51) in patients with cataract and 2.54 (1% CI, 1.26-5.07) in patients with conduction disorders. Multivariate analysis revealed that MIRS was the only independent predictor for conduction disorders and restrictive lung disease. MIRS ≥3 and MIRS ≥4 were the best simple cutoff values to predict, respectively, lung and cardiac involvements.To conclude, muscular disability, ophthalmologic, and cardiac and pulmonary involvement are strongly correlated. Particular attention should be given to these entities in patients with distal or proximal muscular weakness.

摘要

1型强直性肌营养不良(DM1)是一种多系统疾病,其特征为肌肉无力和多器官损害,尤其是眼睛、肺和心脏。我们开展了本研究,以分析这些疾病的患病率及其相互关系,以及它们与肌肉残疾的各自关系。我们评估了106例DM1患者(48例男性和58例女性)的病史、人体测量数据、肺容量、动脉和静脉血样、12导联体表心电图、超声心动图、眼科检查以及肌肉损伤评定量表(MIRS),这些患者年龄为43.7±12.8岁。分别有25.6%、47.6%和17.1%的患者存在肥胖、高甘油三酯血症和糖尿病。43.4%的患者存在致残性白内障,年龄和MIRS可独立预测其发生。34%的患者存在限制性肺病,MIRS、CTG重复序列扩增和体重指数可预测其发生。30.2%的患者存在传导障碍,左心室射血分数、MIRS和CTG重复序列扩增可预测其发生。我们发现白内障、限制性肺病和传导障碍之间存在显著关系:患有白内障和传导障碍的患者比其他患者表现出更严重的限制性肺病。相反,患有白内障的患者发生限制性肺病的相对风险为2.42(1%置信区间[CI],1.06 - 5.51),患有传导障碍的患者为2.54(1%CI,1.26 - 5.07)。多变量分析显示,MIRS是传导障碍和限制性肺病的唯一独立预测因素。MIRS≥3和MIRS≥4分别是预测肺部和心脏受累的最佳简单临界值。总之,肌肉残疾、眼科以及心脏和肺部受累密切相关。对于有远端或近端肌肉无力的患者,应特别关注这些情况。

相似文献

1
Organ dysfunction and muscular disability in myotonic dystrophy type 1.1型强直性肌营养不良中的器官功能障碍和肌肉残疾
Medicine (Baltimore). 2011 Jul;90(4):262-268. doi: 10.1097/MD.0b013e318226046b.
2
Age, conduction defects and restrictive lung disease independently predict cardiac events and death in myotonic dystrophy.年龄、传导缺陷和限制性肺部疾病独立预测肌强直性营养不良的心脏事件和死亡。
Int J Cardiol. 2013 Jan 20;162(3):172-8. doi: 10.1016/j.ijcard.2011.05.070. Epub 2011 Jun 2.
3
Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1.93例1型强直性肌营养不良中国患者的多系统损害
Front Neurol. 2020 Apr 21;11:277. doi: 10.3389/fneur.2020.00277. eCollection 2020.
4
Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center.1 型肌强直性营养不良(DM1)预后的预测因素:单中心 18 年的纵向研究经验。
Acta Myol. 2020 Sep 1;39(3):109-120. doi: 10.36185/2532-1900-015. eCollection 2020 Sep.
5
Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.预测 1 型肌强直性营养不良(DM1)患者呼吸功能下降的因素:一项纵向队列研究。
Acta Neurol Belg. 2021 Feb;121(1):133-142. doi: 10.1007/s13760-020-01425-z. Epub 2020 Jul 10.
6
[Muscular disability and organ impairments in myotonic dystrophy type 1].1型强直性肌营养不良中的肌肉残疾和器官损害
Rev Neurol (Paris). 2011 Jan;167(1):23-8. doi: 10.1016/j.neurol.2010.07.026. Epub 2010 Oct 8.
7
Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study.临床应用生物电阻抗分析评估 1 型肌强直性营养不良患者:一项横断面研究。
Nutrition. 2019 Nov-Dec;67-68:110546. doi: 10.1016/j.nut.2019.05.012. Epub 2019 Jul 2.
8
Myotonic dystrophy type 1: A comparison between the adult- and late-onset subtype.1 型肌强直性营养不良:成人发病型与晚发型亚型的比较。
Muscle Nerve. 2023 Feb;67(2):130-137. doi: 10.1002/mus.27766. Epub 2022 Dec 22.
9
Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).1型强直性肌营养不良患者的功能损害可通过共济失调评定量表(SARA)进行评估。
J Neurol. 2017 Apr;264(4):701-708. doi: 10.1007/s00415-017-8399-x. Epub 2017 Feb 6.
10
Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.I型强直性肌营养不良症传导疾病进展的临床预测因素
Pacing Clin Electrophysiol. 2011 Feb;34(2):171-6. doi: 10.1111/j.1540-8159.2010.02905.x. Epub 2010 Oct 14.

引用本文的文献

1
Skeletal muscle disorders as risk factors for type 2 diabetes.骨骼肌疾病作为2型糖尿病的风险因素。
Mol Cell Endocrinol. 2025 Apr 1;599:112466. doi: 10.1016/j.mce.2025.112466. Epub 2025 Jan 21.
2
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1.1型强直性肌营养不良中心脏事件和猝死背后的CTG重复序列长度
Eur Heart J Open. 2024 Sep 18;4(5):oeae078. doi: 10.1093/ehjopen/oeae078. eCollection 2024 Sep.
3
The Role of Cognition, Affective Symptoms, and Apathy in Treatment Adherence with Noninvasive Home Mechanical Ventilation in Myotonic Dystrophy.
认知、情感症状和淡漠在肌强直性营养不良患者无创家庭机械通气治疗依从性中的作用。
J Neuromuscul Dis. 2024;11(5):1123-1130. doi: 10.3233/JND-240081.
4
Neuronal innervation regulates the secretion of neurotrophic myokines and exosomes from skeletal muscle.神经元支配调节骨骼肌神经营养性肌因子和外泌体的分泌。
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2313590121. doi: 10.1073/pnas.2313590121. Epub 2024 Apr 29.
5
Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value.强直性肌营养不良1型心脏受累的超声心动图特征:患病率及预后价值
J Clin Med. 2023 Mar 1;12(5):1947. doi: 10.3390/jcm12051947.
6
Assessment of body composition, metabolism, and pulmonary function in patients with myotonic dystrophy type 1.评估 1 型肌强直性营养不良患者的身体成分、代谢和肺功能。
Medicine (Baltimore). 2022 Sep 9;101(36):e30412. doi: 10.1097/MD.0000000000030153.
7
Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1.93例1型强直性肌营养不良中国患者的多系统损害
Front Neurol. 2020 Apr 21;11:277. doi: 10.3389/fneur.2020.00277. eCollection 2020.
8
Diabetes, metformin and cancer risk in myotonic dystrophy type I.Ⅰ型肌强直性营养不良中的糖尿病、二甲双胍与癌症风险。
Int J Cancer. 2020 Aug 1;147(3):785-792. doi: 10.1002/ijc.32801. Epub 2019 Dec 19.
9
MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.1型强直性肌营养不良患者躯干肌肉的磁共振成像以及运动和呼吸功能
BMC Neurol. 2019 Jun 19;19(1):135. doi: 10.1186/s12883-019-1357-8.
10
Respiratory management of patients with neuromuscular disease: current perspectives.神经肌肉疾病患者的呼吸管理:当前观点
Degener Neurol Neuromuscul Dis. 2016 Nov 18;6:111-118. doi: 10.2147/DNND.S87323. eCollection 2016.